RA Capital Healthcare Fund LP 的 Form 4 申報
Fulcrum Therapeutics, Inc.（FULC），2023/1/6 申報
- 申報編號
- 0001104659-23-001881
- 申報時間
- 2023/1/6 16:39 ET
- 交易日
- 2023/1/4
- 申報延遲
- 2 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 2 筆非衍生性交易。公開市場買進合計 $131.5 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| RA Capital Healthcare Fund LPCIK 0001315082 | 持股 10% 以上大股東 |
| Ra Capital Management, L.P.CIK 0001346824 | 持股 10% 以上大股東 |
| Kolchinsky PeterCIK 0001384859 | 持股 10% 以上大股東 |
| Shah Rajeev M.CIK 0001619841 | 持股 10% 以上大股東 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
This transaction was executed in multiple trades at prices ranging from $6.64 to $7.63; the price reported above reflects the weighted average purchase price. The reporting person hereby undertakes, upon request, to provide full information to the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer regarding the number of shares and prices at which these transactions, and all other transactions reported in this Form 4, were effected.
表 I 有 1 筆交易的價格引用這則附註。
- F3
This transaction was executed in multiple trades at prices ranging from $7.64 to $8.00; the price reported above reflects the weighted average purchase price. The reporting person hereby undertakes, upon request, to provide full information to the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer regarding the number of shares and prices at which these transactions, and all other transactions reported in this Form 4, were effected.
表 I 有 1 筆交易的價格引用這則附註。